Cinclus Pharma (CINPHA) — Defensive Interval Ratio

Latest as of June 2026: 0 days

Cinclus Pharma (CINPHA) has a Defensive Interval Ratio of 0 days as of June 2026. Defensive assets of Skr0.00 (cash Skr-, short-term investments Skr-, receivables Skr0.00) cover 0 days of daily cash needs of Skr495.94K/day.

Defensive Interval Ratio

0 days
Days of operational coverage

Defensive Assets

Skr0.00
Cash + ST Investments + Receivables

Daily Cash Need

Skr495.94K
Current Liabilities ÷ 365

Current Liabilities

Skr181.02 Million
SEK

Cinclus Pharma Defensive Interval Ratio (2024–2025)

This chart shows how Cinclus Pharma's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the ratio stands at 0 days, meaning defensive assets of Skr0.00 can fund 0 days of operations without new revenue. For the complete balance sheet picture, see CINPHA total assets.

Annual Defensive Interval Ratio for Cinclus Pharma (2024–2025)

The table below presents the year-by-year Defensive Interval Ratio for Cinclus Pharma from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See working capital to net assets of Cinclus Pharma to evaluate short-term liquidity relative to the company's equity base.

Year DIR (days) Defensive Assets (SEK) Daily Cash Need Cash ST Investments Change (days)
2025 43 days Skr16.06 Million Skr374.77K/day Skr- Skr- ▲ +43 days
2024 0 days Skr0.00 Skr124.64K/day Skr- Skr-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)